Atlas Trials

A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations

Clinical trial NCT04686669 · COMPLETED

Trial details

NCT number
NCT04686669
Sponsor
Forendo Pharma Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relative Bioavailability
Start date
2020-12-10
Primary completion
2021-01-16
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.